期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

急性冠脉综合征早期他汀类药物治疗的目的和机制 被引量：6

下载PDF
导出
摘要 急性冠脉综合征早期采用他汀类药物治疗是最近两年中的热门研究课题之一,本文讨论这一治疗方案的目的和机制.
作者 施仲伟
机构地区 上海第二医科大学瑞金医院心脏科
出处 《中国医药导刊》 2002年第2期125-126,128,共3页 Chinese Journal of Medicinal Guide
关键词 急性冠脉综合征 药物疗法 早期治疗 他汀类药物 作用机制
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献14

  • 1[1]Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444. patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet, 1994; 344(8934):1383～1389
  • 2[2]Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New Engl J Med, 1996; 335(14): 1001～1009
  • 3[3]The Long - term Intervention with Pravastatin in Ischemic Disese (LIPID) Study Group. Prevention of cardiovsscular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. New Engl J Med, 1998; 339(19): 1349～1357
  • 4[4]Sacks FM. Lipid - lowering therapy in acute coronary syndromes. JAMA,2001; 285(13) :1758～1760
  • 5[5]Fonarow GC, Gawlinski A. Rationale and design of the Cardiac Hospitalization Atherosclerosis Management Prograrm. at the University of California Los Angeles. Am J Cardiol, 2000; 85(3A): 10A～17A
  • 6[6]Fonarow GC, Gawlinski A, Moughrabi S, et al. Improved treatment of coronary heart disease by implenentation of a cardiac hospitalization atherosclerosis management progeam (CHAMP). Am J Cardiol, 2001; 87(7):819～822
  • 7[7]Waters DD, Hsue PY. What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes? Am J Cardiol, 2001; 88(suppl):7J～16J
  • 8[8]Waters D. Cholesterol lowering: should it continue to be the last thing we do? Circulation, 1999; 99(25) :3215～3217
  • 9[9]Gould KL, Martucci JP, Goldberg DI, et al. Short - term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease: a potential noninvasive marker of healing coronary endothelium.Circulation, 1994; 89(4): 1530～1538
  • 10[10]O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-c o enzyme A reductase inhibitor, improves endothelial function within 1 nonth. Circulation, 1997; 95(5):1126～1131

同被引文献32

  • 1陈永芳 刘亚来 王琳.无痛性心肌缺血性冠心病.中国医学文摘：内科学,2003,:502-503.
  • 2Kayikcioglu M, Turkoglu C, Kultursay H, et al. The short term results of combined use of pravastatin with thrombolytic therapy in acute myocardial infarction. Circulation, 1999;100(18, Suppl I):I- 303
  • 3Arntz H - R, Agrawal R, Wunderlich W, et al. Beneficial effects of pravastatin (±colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] study). AmJ Cardiol, 2000; 86(12):1293 ～ 1298
  • 4Aronow HD, Topol EJ, Roe M, et al. Effect of lipid - lowering therapy on early mortality after acute coronary syndromes: an observational study. Lancet, 2001;357(9262): 1063 ～ 1068
  • 5Cannon CP, McCabe CH, Bentley J, et al. Early statin therapy is associated with markedly lower mortality in patients with acute coronary syndromes: observations from OPUS - TIMI 16. J Am Coil Cardiol, 2001; 37(2, Suppl A): 334A
  • 6Stenestrand U, Wallentin L, for the Swedish Register of Cardiac Intensive Care (RIKS - HLA) . Early stat. in treatment following acute myocardial infarction and 1 - year survival. JAMA, 2001; 285(4) :430 ～ 436
  • 7McG uireDK, O'sheaJC, DykeCK, etal. Highlights fron the XXⅡI Congress of the European Society of Cardiology: August 26 to 30, 2000. Am Heart J, 2001;141(1): 164～ 172
  • 8Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: a randomized controlled trial. JAMA, 2001;285(13):1711～1718
  • 9ThackraySDR, WitteKKA, KhandA, etal. Clinical trials update: highlights of the scientific sessions of the American Heart Association year 2000: Val HeFT,COPERNICUS, MERIT, CIBIS- Ⅱ, BEST, AMIOVIRT, V- MAC, BREAKTHE, HEAT, MIRACL, FLORIDA, VIVA and the first human cardiac skeletal muscle myoblast transfer for heart failure. Eur J Heart Fail, 2001 ;3(1): 117 ～ 124
  • 10SacksFM. Lipid - lowering therapy in acute coronary syndromes. JAMA, 2001;285(13): 1758- 1760

引证文献6

二级引证文献17

中国医药导刊
2002年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部